One-year clinical outcomes of different coronary drug eluting stents-Data from a prospective registry

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomaterials Science

Background:

• Drug-eluting stents (DES) are crucial in percutaneous coronary interventions.
• A prospective registry compared outcomes of imported versus indigenous DES.
• Focus on cost-effective Indian DES lacking extensive clinical trials.

Discussion:

• Propensity score matching ensured comparable patient groups.
• One-year follow-up data analyzed for primary composite endpoint (mortality, stent thrombosis, revascularization).
• No significant differences observed between imported and indigenous DES groups.

Key Insights:

• Indigenous drug-eluting stents (DES) show comparable one-year clinical outcomes to imported DES.
• Cost-effective Indian DES provide a viable alternative without compromising patient safety or efficacy.
• Study addresses the clinical performance of economical DES in a real-world setting.

Outlook:

• Further long-term studies can validate these findings.
• Potential for wider adoption of cost-effective indigenous DES.
• Implications for healthcare policy and patient access to cardiovascular treatments.